MeSH tree: C01.925.256.430.400.100
In an editorial published in the New England Journal of Medicine, University of Michigan Health hepatologist Anna S. Lok, M.D., hails newly announced results of the B-Well clinical trials as "a major step toward a functional ...
11 hours ago
0
5
Fifteen years ago, doctors in Europe noticed a remarkable thing happening in people with chronic hepatitis B infections. When patients went off their medications, the virus started to come back—and then some of the patients ...
May 14, 2026
0
9
Millions of people worldwide carry viral infections they acquired at birth, often for life. For a long time it was assumed that the immune system hardly fights these pathogens. Researchers from the University of Basel show ...
Apr 28, 2026
0
11
Delaying hepatitis B vaccination after birth increases infections among newborns and decreases their survival rates and quality of life, according to a new Cornell University study. The longer the delay, the study found, ...
Apr 27, 2026
0
17
Chronic hepatitis B is substantially prevalent across the European Union and European Economic Area (EU/EEA), affecting an estimated 0.7% of the population in the region in 2022, according to a new study published in Eurosurveillance. ...
Apr 13, 2026
0
2
Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and hepatocellular cancer (HCC, liver cancer). It affects approximately 296 million people worldwide. Hepatitis ...
Mar 2, 2026
0
7
Hepatitis B is a virus that can damage the liver and lead to lifelong health problems. The hepatitis B vaccine prevents short-term illness (acute hepatitis) and a life-threatening infection called chronic hepatitis B.
Jan 5, 2026
0
32
Illinois should continue to recommend that nearly all newborns be vaccinated against hepatitis B, a state advisory committee decided Tuesday, in a move that could represent another break with federal vaccine guidance.
Dec 17, 2025
0
11
TherVacB, a therapeutic vaccine for chronic hepatitis B, has entered its first clinical trial in patients. The first patient was enrolled in June 2025 and treated with the vaccine. In a previous trial in healthy volunteers, ...
Jul 24, 2025
0
33
Menzies School of Health Research has led the largest-ever study of people living with a unique strain of chronic hepatitis B (C4 hepatitis B)—which predominately affects First Nations Australians in the Northern Territory ...
Jul 14, 2025
0
10
